CN103893337A - Traditional Chinese medicine topical agent for treating intestine function recovery after cesarean section - Google Patents
Traditional Chinese medicine topical agent for treating intestine function recovery after cesarean section Download PDFInfo
- Publication number
- CN103893337A CN103893337A CN201410127300.6A CN201410127300A CN103893337A CN 103893337 A CN103893337 A CN 103893337A CN 201410127300 A CN201410127300 A CN 201410127300A CN 103893337 A CN103893337 A CN 103893337A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- traditional chinese
- herba
- cesarean section
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine topical agent for treating intestine function recovery after cesarean section. The motherland medicine thinks that the disease mainly belongs to the domains of the diseases such as postpartum fever, hypogalactia, obstructed latex and uterine bleeding in the traditional Chinese medicine. The pathogenesis of the disease mainly comprises qi-blood deficiency, blocked extravasated blood and qi depression. The traditional Chinese medicinal materials with the functions of reinforcing qi, nourishing blood, regulating flow of vital energy and removing stasis, such as diverseleaf fig fruit, two-color sealavander herb, hance rosewood stem or root, exocarpium, scarlet kadsura root, hamilton clubmoss herb, Indian kalimeris herb and henry ormosia wood or root are selected to be decocted into soup by the department of pharmaceutical preparation in our hospital. The total effective rate can be up to 86.0% and much better than that of a control group by a clinical test.
Description
Technical field
The invention belongs to medical sanitary technology field, relate to a kind of Chinese medicine composition, relate in particular to a kind of external application of Chinese medicine agent for the treatment of intestinal function recovery after cesarean section.
Background technology
Cesarean section is as a kind of intervention means of obstetric delivery, in recent years due to improvement, the optimization of modus operandi, and the impact of all sectors of society many factors, cut open palace productive rate in continuous rising, its post-operative complication also has increasing gesture, as bad in the postoperative involution of uterus, and many and persistent period of lochia amount extends, galactopoiesis deficiency causes breastfeeding rate and declines, and postoperative sickness rate and infection are increased etc.After cesarean section, abdominal distention is that obstetrics common clinical symptoms, especially uterine cicatrix more easily occur, and puerpera is extremely painful therefrom.Gastrointestinal function recovery after operation can not recover smoothly, not only has a strong impact on patient postoperative rehabilitation, also can cause patient's multiple organ dysfunction.Reducing cesarean section infectious-related complication, promote the aspects such as the involution of uterus at present, doctor trained in Western medicine is all symptomatic treatments, can not make overall plans, both increase puerpera's financial burden, have again certain side effect, but China's Traditional Chinese Medicine Chinese medicine has good curative effect, and puerpera and neonate are had no adverse effects.
Summary of the invention
The object of this invention is to provide a kind of external application of Chinese medicine agent for the treatment of intestinal function recovery after cesarean section.Motherland's medical science thinks that primary disease belongs to the disease categories such as traditional Chinese medical science puerperal fever, hypogalactia, galactostasis, metrorrhagia more.Primary disease pathogenesis mostly is QI and blood deficiency, congestion retardance, and disorder of QI movement, treatment mostly is benefiting QI and nourishing blood, and the blood stasis dispelling of regulating the flow of vital energy is method.
The object of the invention is to be achieved through the following technical solutions, after this treatment cesarean section, the external application of Chinese medicine agent of intestinal function recovery is made up of the Chinese medicine of following weight portion: Fructus Fici Heteromo 30-60 part, Herba Limoii Bicoloris 15-30 part, Caulis Dalbergiae Hancei 6-9 part, Exocarpium Citri Grandis 3-6 part, Radix Kadsurae Coccineae 12-30 part, Herba urticae macrorrhizae 9-15 part, Herba Kalimeridis 9-18 part, lignum Ormosiae henryi 6-9 part.
Preferably, 45 parts of Fructus Fici Heteromos, 22 parts of Herba Limoii Bicoloriss, 7 parts of Caulis Dalbergiae Hanceis, 5 parts of Exocarpium Citri Grandises, 21 parts of Radix Kadsurae Coccineae, 12 parts of Herba urticae macrorrhizaes, 14 parts of Herba Kalimeridis, 7 parts of lignum Ormosiae henryi.
Preparation method: above-mentioned Chinese medicine is ground to coarser powder and add Chinese liquor furnishing pasty state.
Fang Zhong: Fructus Fici Heteromo is enriched blood, stimulating milk secretion; Herba Limoii Bicoloris is enriched blood, hemostasis, dissipating blood stasis, regulating menstruation; Caulis Dalbergiae Hancei promoting the circulation of QI to relieve pain, removing mass; Exocarpium Citri Grandis regulate the flow of vital energy stomach invigorating, reducing phlegm helps digestion; Radix Kadsurae Coccineae promoting the circulation of QI to relieve pain, promoting blood circulation to remove blood stasis; Herba urticae macrorrhizae removing blood stasis, pain relieving, detumescence, heat clearing away; Herba Kalimeridis heat-clearing and toxic substances removing, removing food stagnancy, dissipating blood stasis, hemostasis; Lignum Ormosiae henryi blood circulation promoting and blood stasis dispelling, the detumescence of dispeling the wind.
Clinical data
1, physical data 100 examples are the puerpera after cesarean section, are divided at random treatment group and matched group, treatment group 50 examples, age 18-40 year, multipara's 10 examples, primipara's 40 examples, 23.4 years old mean age; Matched group 50 examples, multipara's 14 examples, primipara's 36 examples, at 18～37 years old age, 23.4 years old mean age, two groups of ordinary circumstances are without significant difference (P > 0.05).
2, Therapeutic Method treatment group: take above-mentioned Chinese medicine Fructus Fici Heteromo 45g, Herba Limoii Bicoloris 22g, Caulis Dalbergiae Hancei 7g, Exocarpium Citri Grandis 5g, Radix Kadsurae Coccineae 21g, Herba urticae macrorrhizae 12g, Herba Kalimeridis 14g, lignum Ormosiae henryi 7g.After operation, in 30min, above-mentioned Chinese medicine mixing is ground to coarser powder and add Chinese liquor furnishing pasty state, spread on SHENQUE acupoint (umbilical part), every 12h changes dressings 1 time.
Matched group: press post gynecologic operation conventional therapy.
Observe and record the time that two groups of postoperative borborygmus of patient and passage of gas by anus occur.
3, curative effect determinate standard finishes go back to ward to micturition time as peristalsis taking operation, and < 24h is effective, and 24-48h is effectively, is effectively always generically and collectively referred to as effectively with effective, and > 48h is invalid.
4, therapeutic outcome treatment group 50 examples, wherein effective 15 examples (30.0%), effective 28 examples (56.0%), invalid 7 examples (14.0%), total effective rate 86.0%; Matched group 50 examples, wherein effective 10 examples (20.0%), effective 20 examples (40.0%), invalid 20 examples (40.0%), total effective rate 60.0%.Two groups of comparisons, treatment group obvious effective rate, total effective rate are obviously better than matched group, have comparability.P＜0.05。
Detailed description of the invention
Embodiment mono-: take Fructus Fici Heteromo 45g, Herba Limoii Bicoloris 22g, Caulis Dalbergiae Hancei 7g, Exocarpium Citri Grandis 5g, Radix Kadsurae Coccineae 21g, Herba urticae macrorrhizae 12g, Herba Kalimeridis 14g, lignum Ormosiae henryi 7g.After operation, in 30min, above-mentioned Chinese medicine mixing is ground to coarser powder and add Chinese liquor furnishing pasty state, spread on SHENQUE acupoint (umbilical part), every 12h changes dressings 1 time.
Embodiment bis-: take Fructus Fici Heteromo 30g, Herba Limoii Bicoloris 30g, Caulis Dalbergiae Hancei 6g, Exocarpium Citri Grandis 6g, Radix Kadsurae Coccineae 12g, Herba urticae macrorrhizae 15g, Herba Kalimeridis 18g, lignum Ormosiae henryi 6g.After operation, in 30min, above-mentioned Chinese medicine mixing is ground to coarser powder and add Chinese liquor furnishing pasty state, spread on SHENQUE acupoint (umbilical part), every 12h changes dressings 1 time.
Embodiment tri-: take Fructus Fici Heteromo 60g, Herba Limoii Bicoloris 15g, Caulis Dalbergiae Hancei 9g, Exocarpium Citri Grandis 3g, Radix Kadsurae Coccineae 30g, Herba urticae macrorrhizae 9g, Herba Kalimeridis 9g, lignum Ormosiae henryi 9g.After operation, in 30min, above-mentioned Chinese medicine mixing is ground to coarser powder and add Chinese liquor furnishing pasty state, spread on SHENQUE acupoint (umbilical part), every 12h changes dressings 1 time.
Claims (2)
1. treat an external application of Chinese medicine agent for intestinal function recovery after cesarean section, it is characterized in that this external application of Chinese medicine agent is made up of the Chinese medicine of following weight portion: Fructus Fici Heteromo 30-60 part, Herba Limoii Bicoloris 15-30 part, Caulis Dalbergiae Hancei 6-9 part, Exocarpium Citri Grandis 3-6 part, Radix Kadsurae Coccineae 12-30 part, Herba urticae macrorrhizae 9-15 part, Herba Kalimeridis 9-18 part, lignum Ormosiae henryi 6-9 part.
2. a kind of external application of Chinese medicine agent for the treatment of intestinal function recovery after cesarean section as claimed in claim 1, it is characterized in that this external application of Chinese medicine agent is preferred, made by the Chinese medicine of following weight portion: 45 parts of Fructus Fici Heteromos, 22 parts of Herba Limoii Bicoloriss, 7 parts of Caulis Dalbergiae Hanceis, 5 parts of Exocarpium Citri Grandises, 21 parts of Radix Kadsurae Coccineae, 12 parts of Herba urticae macrorrhizaes, 14 parts of Herba Kalimeridis, 7 parts of lignum Ormosiae henryi.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410127300.6A CN103893337B (en) | 2014-03-26 | 2014-03-26 | A kind of external traditional Chinese medicinal application for the treatment of cesarean postoperate intestinal function recovery |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410127300.6A CN103893337B (en) | 2014-03-26 | 2014-03-26 | A kind of external traditional Chinese medicinal application for the treatment of cesarean postoperate intestinal function recovery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103893337A true CN103893337A (en) | 2014-07-02 |
| CN103893337B CN103893337B (en) | 2015-09-02 |
Family
ID=50985123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410127300.6A Expired - Fee Related CN103893337B (en) | 2014-03-26 | 2014-03-26 | A kind of external traditional Chinese medicinal application for the treatment of cesarean postoperate intestinal function recovery |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103893337B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105125628A (en) * | 2015-09-21 | 2015-12-09 | 江志鑫 | Foot bath care solution capable of promoting intestinal function recovery after abdominal operations |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101468078A (en) * | 2007-12-28 | 2009-07-01 | 天津中新药业集团股份有限公司乐仁堂制药厂 | Chinese medicinal compound suppository for treating constipation and preparation method thereof |
| CN102274394A (en) * | 2010-06-12 | 2011-12-14 | 湖南天龙制药有限公司 | Chinese medicinal composition for treating postnatal constipation |
-
2014
- 2014-03-26 CN CN201410127300.6A patent/CN103893337B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101468078A (en) * | 2007-12-28 | 2009-07-01 | 天津中新药业集团股份有限公司乐仁堂制药厂 | Chinese medicinal compound suppository for treating constipation and preparation method thereof |
| CN102274394A (en) * | 2010-06-12 | 2011-12-14 | 湖南天龙制药有限公司 | Chinese medicinal composition for treating postnatal constipation |
Non-Patent Citations (2)
| Title |
|---|
| 李贺云；等: "慢性功能性便秘的中医药治疗进展", 《国医论坛》 * |
| 王维恒: "产后大便难如何综合调治", 《中医杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105125628A (en) * | 2015-09-21 | 2015-12-09 | 江志鑫 | Foot bath care solution capable of promoting intestinal function recovery after abdominal operations |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103893337B (en) | 2015-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN104523865A (en) | Medicine for treating breast diseases | |
| CN104758890A (en) | Traditional Chinese medicine composition for treating cough | |
| CN104547297A (en) | Medicine for treating cholecystitis | |
| CN102949695B (en) | Traditional Chinese medicine for treating intractable hiccough | |
| CN102973677A (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN105434972A (en) | Traditional Chinese medicine composition for treating breast hyperplasia | |
| CN103893337B (en) | A kind of external traditional Chinese medicinal application for the treatment of cesarean postoperate intestinal function recovery | |
| CN104606523A (en) | Traditional Chinese medicine composition treating children's measles | |
| CN103690621A (en) | Traditional Chinese medicine decoction for treating scapulohumeral periarthritis | |
| CN103263645B (en) | Gastritis and gastric ulcer treatment drug | |
| CN103191345B (en) | Postoperative drug for chronic peptic ulcer and esophagitis syndrome | |
| CN103372185B (en) | The medicine for the treatment of chronic bronchitis | |
| CN105943744A (en) | Traditional Chinese medicine composition for treating retention of urine | |
| CN104688901A (en) | Traditional Chinese medicine topical agent for preventing constipation of patients with acute myocardial infarction and nursing method | |
| CN105853782A (en) | Traditional Chinese medicinal composition for treating uterine prolapsed | |
| CN105287954A (en) | Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type postpartum abdominal pain | |
| CN105560994A (en) | Traditional Chinese medicine composition for treating prolapse of uterus | |
| CN104398596A (en) | Traditional Chinese medicinal formula for treating oral ulcer | |
| CN104258130A (en) | Traditional Chinese medicinal preparation for treating chronic urticaria | |
| CN104474210A (en) | Traditional Chinese medicine composition for treating unstable angina pectoris caused by qi stagnation and blood stasis | |
| CN104306936A (en) | Composition for treating chronic urticaria | |
| CN104491028A (en) | Traditional Chinese medicine composition for treating gallstones | |
| CN104161885A (en) | Traditional Chinese medicine for treating vasculitis, and preparation method of pill | |
| CN104056174A (en) | Traditional Chinese medicine combination assisting in treating Hashimoto disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150902 Termination date: 20160326 |